1: Konieczny J, Czarnecka A, Kamińska K, Lenda T, Nowak P. Decreased behavioral response to intranigrally administered GABAA agonist muscimol in the lactacystin model of Parkinson's disease may result from partial lesion of nigral non-dopamine neurons: comparison to the classical neurotoxin 6-OHDA. Behav Brain Res. 2015 Apr 15;283:203-14. doi: 10.1016/j.bbr.2015.01.043. Epub 2015 Feb 2. PubMed PMID: 25655509.
2: Harrison IF, Crum WR, Vernon AC, Dexter DT. Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors. Br J Pharmacol. 2015 Aug;172(16):4200-15. doi: 10.1111/bph.13208. Epub 2015 Jul 8. PubMed PMID: 26040297; PubMed Central PMCID: PMC4543623.